Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

BACKGROUND: Lenalidomide could effectively induce red blood cell (RBC) transfusion independence (TI) in patients with lower-risk (Low/Intermediate-1) myelodysplastic syndrome (MDS) with or without 5q deletion. However whether lenalidomide ultimately improves the overall survival (OS) of lower-risk M...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Xin-yue, Zhang, Zhi-hui, Deng, Zhao-qun, He, Pin-fang, Yao, Dong-ming, Xu, Zi-jun, Wen, Xiang-mei, Yang, Lei, Lin, Jiang, Qian, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100926/
https://www.ncbi.nlm.nih.gov/pubmed/27824902
http://dx.doi.org/10.1371/journal.pone.0165948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100926/
https://www.ncbi.nlm.nih.gov/pubmed/27824902
http://dx.doi.org/10.1371/journal.pone.0165948

Ejemplares similares